Mycoplasma Pneumoniae Antibody (IgG) testing plays a pivotal role in the serological diagnosis of infections caused by the bacterium Mycoplasma pneumoniae, a common agent of atypical pneumonia and other respiratory tract infections.
This antibody is a specific type of immunoglobulin G (IgG), which the human immune system produces in response to an infection with this organism.
The presence and levels of Mycoplasma pneumoniae IgG antibodies in a patient's blood are measured to determine whether they have been exposed to the pathogen, either in the recent past or as a more distant infection. Typically, the body starts producing these antibodies 1-2 weeks after the initial infection, and their levels peak around 4-6 weeks post-infection.
The detection of IgG antibodies is crucial because it indicates a past or ongoing immune response against Mycoplasma pneumoniae.
However, it's important to note that the presence of IgG antibodies alone cannot definitively confirm an active infection, as they can persist in the bloodstream for months or even years after the initial exposure, indicating immunity from past infection.
Therefore, the interpretation of Mycoplasma pneumoniae IgG tests often involves considering the patient's clinical presentation, symptoms, and, if available, comparing antibody titers from acute and convalescent phases of the illness. This comparison can help to ascertain whether the detected antibodies are from a recent infection or a past exposure. In some cases, the testing for IgM antibodies, which are produced earlier in the infection, might be conducted alongside IgG testing for a more comprehensive understanding of the infection's timeline. Mycoplasma pneumoniae IgG antibody testing is a valuable tool in the epidemiological tracking and management of respiratory infections, particularly in outbreak settings or when diagnosing atypical pneumonia cases.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.